Create a free research account to view current pricing and place an order.
How does CJC/Ipamorelin Blend work in research models?
CJC-1295 No DAC is a GHRH analog that stimulates pituitary GHRH receptors to promote pulsatile endogenous GH release. No-DAC versions are short acting and often timed around fasted or bedtime GH-axis windows. Ipamorelin is a selective ghrelin receptor/GHSR agonist researched for GH pulse support with comparatively lower prolactin and cortisol signaling than older GHRPs.
What is the half-life of CJC/Ipamorelin Blend?
Half-life: Short acting blend.
Blend pharmacokinetics vary by component. Operational timing should be based on the dominant pathway and the most sensitivity-prone ingredient.
Research dosing reference
200-400 mcg total blend one to two times daily.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 200 mcg | 4 units |
| 300 mcg | 6 units |
| 400 mcg | 8 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is CJC/Ipamorelin Blend reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5/5 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Often used before bed or during fasted windows to align with GH-axis signaling and reduce food-related interference.
Beginner escalation
Begin conservatively while monitoring hunger, edema, sleep quality, glucose response, and tingling/carpal-tunnel-like symptoms.
Side-effect mitigation
Monitor water retention, increased hunger, flushing, glucose variability, joint stiffness, or tingling. Periodic IGF-1 and glucose monitoring may be appropriate in longer protocols.
Stack compatibility
GH-axis agents stack most logically with complementary GH secretagogues; avoid overbuilding GH-axis stacks without monitoring IGF-1, glucose, and edema response.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
GH-axis protocols should reassess every 8-12 weeks: IGF-1, fasting glucose/A1c where appropriate, edema, sleep quality, hunger, body-composition objectives, and continued need.
Frequently asked questions
What is CJC/Ipamorelin Blend and how is it studied?
CJC-1295 No DAC is a GHRH analog that stimulates pituitary GHRH receptors to promote pulsatile endogenous GH release. No-DAC versions are short acting and often timed around fasted or bedtime GH-axis windows. Ipamorelin is a selective ghrelin receptor/GHSR agonist researched for GH pulse support with comparatively lower prolactin and cortisol signaling than older GHRPs. CJC/Ipamorelin Blend is catalogued in the Growth Hormone Axis group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of CJC/Ipamorelin Blend?
Reference half-life for CJC/Ipamorelin Blend: short acting blend. Blend pharmacokinetics vary by component. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is CJC/Ipamorelin Blend stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is CJC/Ipamorelin Blend reconstituted for laboratory work?
The reference reconstitution for the 5/5 mg vial is 2 mL BAC Water, which gives a concentration of about 2.5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is CJC/Ipamorelin Blend FDA approved?
No. The research-grade CJC/Ipamorelin Blend described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration